All Contract Research articles
-
OpinionCould cheap CRO rates threaten to destabilise biotech?
Pharmaceutical pipelines are heavily dependent on contract research organisations; we can’t afford for them to fail
-
BusinessAn evolution in pharma outsourcing
Contract services firms are becoming increasingly sophisticated and embedded in the ecosystem of drug development
-
BusinessHow Covid-19 is changing drug manufacturing
Catalent is adapting, focusing on employee safety and supply chain security
-
ArticlePharma supply chains pick up pace
Contract suppliers are increasingly important in reducing time to market
-
BusinessPatheon buyout brings Thermo into contract manufacturing
$7.2bn deal expands Thermo Fisher’s laboratory products and services segment
-
WhitepaperAnalytical method transfer
Learn about current best practice in a critical field for the industry
-
BusinessJoined-up thinking
The rift between contract medicinal chemistry and chemical development needs to be bridged
-
Business
EU regulator calls for generic drug suspensions
The EMA wants hundreds of formulations off the market after identifying systematic fraud in a major Indian contract clinical research organisation
-
Business
Labcorp to buy Covance and enter contract research
Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
-
Business
Co-operation keeps contracts coming
Clubbing together gives contract research organisations more power to win new business in an evolving market
-
BusinessService with a smile
Company profile: Charnwood Molecular is more than a run-of-the-mill contract synthesis provider